unknown
Stage
2018
Founded
2
Investors
About
BlossomHill Therapeutics is a clinical-stage biotechnology company that designs and develops small-molecule oncology medicines aimed at overcoming treatment resistance and improving selectivity, durability, and safety. Their work focuses on precision cancer therapies and rational drug design to address hard-to-treat tumors.
Explore BlossomHill Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.